Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. Reporting to the General Counsel, the Vice President, Corporate, Securities & Transactions will work closely with the General Counsel on Allogene’s public company corporate legal function, including SEC reporting, corporate governance, Board and committee matters, proxy and annual meeting processes, Section 16 reporting, and related disclosure and compliance matters. The role will also support strategic transactions, business development activities, M&A, licensing and collaboration matters, and the drafting and negotiation of corporate and commercial agreements. This is ideally a hybrid role based at our headquarters in South San Francisco, CA (US-based, west coast remote may be considered for candidates outside of the area).
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree